Diabetic cardiovascular autonomic neuropathy is a frequent complication of diabetes mellitus that requires a multifactorial management approach including lifestyle modifications and glycemic control.
This review outlines the clinical implications, diagnostic tools, and a multifactorial management approach for diabetic cardiovascular autonomic neuropathy.
Diabetic cardiovascular autonomic neuropathy (DCAN), the impairment of the autonomic balance of the cardiovascular system in the setting of diabetes mellitus (DM), is frequently observed in both Type 1 and 2 DM, has detrimental effects on the quality of life and portends increased mortality. Clinical manifestations include: resting heart rate disorders, exercise intolerance, intraoperative cardiovascular lability, orthostatic alterations in heart rate and blood pressure, QT-interval prolongation, abnormal diurnal and nocturnal blood pressure variation, silent myocardial ischemia and diabetic cardiomyopathy. Clinical tests for autonomic nervous system evaluation, heart rate variability analysis, autonomic innervation imaging techniques, microneurography and baroreflex analysis are the main diagnostic tools for DCAN detection. Aldose reductase inhibitors and antioxidants may be helpful in DCAN therapy, but a regular, more generalized and multifactorial approach should be adopted with inclusion of lifestyle modifications, strict glycemic control and treatment of concomitant traditional cardiovascular risk factors, in order to achieve the best therapeutic results. In the present review, the authors provide aspects of DCAN pathophysiology, clinical presentation, diagnosis and an algorithm regarding the evaluation and management of DCAN in DM patients.
Karayannis et al. (Fri,) conducted a review in Diabetic cardiovascular autonomic neuropathy (DCAN). Diabetic cardiovascular autonomic neuropathy is a frequent complication of diabetes mellitus that requires a multifactorial management approach including lifestyle modifications and glycemic control.